FIELD: medicine; cardiology.
SUBSTANCE: invention can be used to determine the probability of coronary heart disease in young people by examining blood serum and determining triglycerides (TG). Total antioxidants (OA) are determined in blood serum by enzyme immunoassay, height and body weight are measured. The diagnostic index is calculated using the following formula YD =1/[1+exp(Sd)], where Sd=OA*1.429+TG*0.002+(body weight, kg/(height, m)2)*0.049-4.312. If the value of the diagnostic index exceeds 0.55, it is determined that young people probability have coronary heart disease.
EFFECT: method provides a significant acceleration of the procedure for obtaining the results of the study and the possibility of using for screening due to the use of the original calculation formula that takes into account the concentration of OA and TG, body weight and height of the patient.
1 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING PROBABILITY OF ISCHEMIC HEART DISEASE IN YOUNG PATIENTS WITH ABDOMINAL OBESITY | 2020 |
|
RU2749293C1 |
METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE AND OBESITY | 2022 |
|
RU2785311C1 |
METHOD FOR DIAGNOSING NON-OBSTRUCTIVE CORONARY ATHEROSCLEROSIS IN MEN WITH SUSPECTED ISCHEMIC HEART DISEASE | 2018 |
|
RU2690405C1 |
METHOD FOR DISLIPIDEMIA PREVENTION | 2016 |
|
RU2621152C1 |
METHOD FOR DIAGNOSIS OF CORONARY ARTERY STENOSIS RESTENOSIS IN PATIENTS WITH CORONARY HEART DISEASE WITH CHRONIC HEART FAILURE | 2017 |
|
RU2649131C1 |
METHOD FOR PREDICTING THE LEVEL OF CARDIO-ANKLE VASCULAR INDEX IN PATIENTS WITH DIABETES OF TYPE 2 IN COMBINATION WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE | 2017 |
|
RU2656535C1 |
METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE | 2023 |
|
RU2818733C1 |
METHOD FOR PREDICTION OF INCREASING ARTERIAL STIFFNESS IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK AND RECEIVING STATIN THERAPY | 2015 |
|
RU2584350C1 |
METHOD FOR PREDICTING CARDIOVASCULAR COMPLICATIONS WITHIN 12 MONTHS AFTER ELECTIVE ENDOVASCULAR MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2020 |
|
RU2749485C1 |
METHOD FOR FORECASTING THE ONE-YEAR RISK OF DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS AFTER STENTING OF CORONARY ARTERIES IN PATIENTS WITH CORONARY HEART DISEASE WITH METABOLIC SYNDROME WITHOUT INSULIN RESISTANCE | 2017 |
|
RU2663496C1 |
Authors
Dates
2023-07-20—Published
2022-05-30—Filed